Influenza Medication Market Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2028

Jan 2018| TMR088A| Transparency

Report Highlights

Global Influenza Medication Market: Overview

This report on Influenza Medication Market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of Influenza Medication Market products such as Zanamivir, Oseltamivir, Peramivir, and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the Global Influenza Medication Market with respect to the leading market segments based on products segment, distribution channels, and geographies.

Global Influenza Medication Market: Key Segments

Based on the product type, the Influenza Medication Market has been segmented into: Zanamivir, Oseltamivir, Peramivir, Amantadine, Rimantadine, Inosine and Others (laninamivir octanoate, etc.). Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of Influenza Medication Market products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Influenza Medication Market: Scope of the Study

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the Influenza Medication Market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global influenza medication market.

Global Influenza Medication Market: Regional Outlook

Geographically, influenza medication market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the Global Influenza Medication Market.

Companies Mentioned in Report

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the Global Influenza Medication Market. The report also profiles key players operating in the Influenza Medication Market which are Daiichi Sankyo Company, GlaxoSmithKline plc, Natco Pharma, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd. and Mylan, Inc..

The global influenza medication market is segmented as follows:

Global Influenza Medication Market, by Product

Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other (Laninamivir Octanoate, etc.)
Global Influenza Medication Market, by Distribution channel

Hospitals
Clinics
Pharmacies
Others
Global Influenza Medication Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Poland
Rest of the Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Rest of Middle East & Africa

  • Table 1 : Global Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 2 : Global Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 3 : Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
  • Table 4 : North America Influenza Medication Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 5 : North America Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 6 : North America Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 7 : Europe Influenza Medication Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 8 : Europe Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 9 : Europe Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 10 : Asia Pacific Influenza Medication Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 11 : Asia Pacific Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 12 : Asia Pacific Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channels, 2015–2025
  • Table 13 : Latin America Influenza Medication Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 14 : Latin America Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 15 : Latin America Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 16 : Middle East & Africa Influenza Medication Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 17 : Middle East & Africa Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
  • Table 18 : Middle East & Africa Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Figure 1 : Global Influenza Medications Market Snapshot
  • Figure 2 : Global Influenza Medication Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 3 : Market Value Share, by Distribution Channels (2016)
  • Figure 4 : Market Value Share, by Product (2016)
  • Figure 5 : Market Value Share, by Region (2016)
  • Figure 6 : Illustration of the Pharmaceutical Price Build-up
  • Figure 7 : Global Influenza Medication Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 8 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Zanamivir, 2015–2025
  • Figure 9 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Oseltamivir, 2015–2025
  • Figure 10 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Peramivir, 2015–2025
  • Figure 11 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Amantadine, 2015–2025
  • Figure 12 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Rimantadine, 2015–2025
  • Figure 13 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Inosine, 2015–2025
  • Figure 14 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Other (Laninamivir Octanoate, etc.), 2015–2025
  • Figure 15 : Global Influenza Medication Market Attractiveness Analysis, by Product, 2015–2025
  • Figure 16 : Global Influenza Medication Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 17 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2015–2025
  • Figure 18 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2015–2025
  • Figure 19 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Pharmacies, 2015–2025
  • Figure 20 : Global Influenza Medication Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2015–2025
  • Figure 21 : Global Influenza Medication Market Attractiveness Analysis, by Distribution Channel, 2015–2025
  • Figure 22 : Global Influenza Medication Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 23 : Global Influenza Medication Market Attractiveness Analysis, by Region, 2017–2025
  • Figure 24 : North America Influenza Medication Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
  • Figure 25 : North America Influenza Medication Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 26 : North America Influenza Medication Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 27 : North America Influenza Medication Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 28 : North America Influenza Medication Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 29 : North America Influenza Medication Market Attractiveness Analysis, by Product, 2015–2025
  • Figure 30 : North America Influenza Medication Market Attractiveness Analysis, by Distribution Channel, 2015–2025
  • Figure 31 : Europe Influenza Medication Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 32 : Europe Influenza Medication Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 33 : Europe Influenza Medication Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 34 : Europe Influenza Medication Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 35 : Europe Influenza Medication Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 36 : Europe Influenza Medication Market Attractiveness Analysis, by Product, 2015–2025
  • Figure 37 : Europe Influenza Medication Market Attractiveness Analysis, by Distribution Channel, 2015–2025
  • Figure 38 : Asia Pacific Influenza Medication Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 39 : Asia Pacific Influenza Medication Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
  • Figure 40 : Asia Pacific Influenza Medication Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 41 : Asia Pacific Influenza Medication Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 42 : Asia Pacific Influenza Medication Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 43 : Asia Pacific Influenza Medication Market Attractiveness Analysis, by Product, 2015–2025
  • Figure 44 : Asia Pacific Influenza Medication Market Attractiveness Analysis, by Distribution Channel, 2015–2025
  • Figure 45 : Latin America Influenza Medication Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
  • Figure 46 : Latin America Influenza Medication Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 47 : Latin America Influenza Medication Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 48 : Latin America Influenza Medication Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 49 : Latin America Influenza Medication Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 50 : Latin America Influenza Medication Market Attractiveness Analysis, by Product, 2015–2025
  • Figure 51 : Latin America Influenza Medication Market Attractiveness Analysis, by Distribution Channel, 2015–2025
  • Figure 52 : Middle East & Africa Influenza Medication Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
  • Figure 53 : Middle East & Africa Influenza Medication Market Attractiveness Analysis, by Country, 2017–2025
  • Figure 54 : Middle East & Africa Influenza Medication Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 55 : Middle East & Africa Influenza Medication Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 56 : Middle East & Africa Influenza Medication Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 57 : Middle East & Africa Influenza Medication Market Attractiveness Analysis, by Product, 2015–2025
  • Figure 58 : Middle East & Africa Influenza Medication Market Attractiveness Analysis, by Distribution Channel, 2015–2025
  • Figure 59 : Global Influenza Medication Market Share Analysis, by Company, 2016 (Estimated)
  • Figure 60 : F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016rv
  • Figure 61 : F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 62 : F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Region (Pharmaceutical Segment), 2016
  • Figure 63 : F. Hoffmann-La Roche Ltd. Breakdown of Net Sales (Overall Company Level), 2016
  • Figure 64 : Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 65 : Teva Pharmaceutical Industries Ltd. R&D Intensity and Sales & Marketing Intensity (%) – Company Level or Segment Level, 2015–2016
  • Figure 66 : Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales, by Region, 2016
  • Figure 67 : Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales (Overall Company Level), 2016
  • Figure 68 : Sandoz International GmbH (Novartis AG) Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 69 : Sandoz International GmbH (Novartis AG) R&D Intensity and Sales & Marketing Intensity (%) – Company Level or Segment Level, 2013–2016
  • Figure 70 : Sandoz International GmbH (Novartis AG) Breakdown of Net Sales, by Region, 2016
  • Figure 71 : Sandoz International GmbH (Novartis AG) Breakdown of Net Sales (Overall Company Level), 2016
  • Figure 72 : Sun Pharmaceutical Industries Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
  • Figure 73 : Sun Pharmaceutical Industries Ltd. R&D Intensity and Sales and Marketing Intensity (%) – Company Level or Segment Level, 2015–2016
  • Figure 74 : Sun Pharmaceutical Industries Ltd. Breakdown of Net Sales, by Region (overall company), 2016
  • Figure 75 : Sun Pharmaceutical Industries Ltd. Breakdown of Net Sales, by Business Segment, 2016
  • Figure 76 : Mylan, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
  • Figure 77 : Mylan, Inc. R&D Intensity and Sales and Marketing Intensity (%) – Company Level or Segment Level, 2015–2016
  • Figure 78 : Mylan, Inc. Breakdown of Net Sales, by Region (overall company), 2016
  • Figure 79 : GlaxoSmithKline plc Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
  • Figure 80 : GlaxoSmithKline plc R&D Intensity (%), 2015–2016
  • Figure 81 : GlaxoSmithKline plc Breakdown of Net Sales, by Region, 2016
  • Figure 82 : GlaxoSmithKline plc Breakdown of Net Sales, by Segment, 2016
  • Figure 83 : Daiichi Sankyo Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 84 : Daiichi Sankyo Company R&D Intensity (%), 2015–2016
  • Figure 85 : Daiichi Sankyo Company Breakdown of Net Sales, by Region, 2016
  • Figure 86 : Natco Pharma Net Sales Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 87 : Natco Pharma R&D Intensity (%), 2015–2016
  • Figure 88 : Natco Pharma Breakdown of Net Sales, by Segment 2017

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report